Disrupted-in-Schizophrenia-1 Attenuates Amyloid- β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β -Site APP-Cleaving Enzyme 1 Levels

Qing-Shan Deng,Xing-Yu Dong,Hao Wu,Wang Wang,Zhao-Tao Wang,Jian-Wei Zhu,Chun-Feng Liu,Wei-Qiang Jia,Yan Zhang,Melitta Schachner,Quan-Hong Ma,Ru-Xiang Xu
DOI: https://doi.org/10.1038/npp.2015.164
2015-01-01
Neuropsychopharmacology
Abstract:Disrupted-in-Schizophrenia-1 (DISC1) is a genetic risk factor for a wide range of major mental disorders, including schizophrenia, major depression, and bipolar disorders. Recent reports suggest a potential role of DISC1 in the pathogenesis of Alzheimer’s disease (AD), by referring to an interaction between DISC1 and amyloid precursor protein (APP), and to an association of a single-nucleotide polymorphism in a DISC1 intron and late onset of AD. However, the function of DISC1 in AD remains unknown. In this study, decreased levels of DISC1 were observed in the cortex and hippocampus of 8-month-old APP/PS1 transgenic mice, an animal model of AD. Overexpression of DISC1 reduced, whereas knockdown of DISC1 increased protein levels, but not mRNA levels of β -site APP-Cleaving Enzyme 1 (BACE1), a key enzyme in amyloid- β (A β ) generation. Reduction of BACE1 protein levels by overexpression of DISC1 was accompanied by an accelerating decline rate of BACE1, and was blocked by the lysosomal inhibitor chloroquine, rather than proteasome inhibitor MG-132. Moreover, overexpression of DISC1 in the hippocampus with an adeno-associated virus reduced the levels of BACE1, soluble A β 40/42, amyloid plaque density, and rescued cognitive deficits of APP/PS1 transgenic mice. These results indicate that DISC1 attenuates A β generation and cognitive deficits of APP/PS1 transgenic mice through promoting lysosomal degradation of BACE1. Our findings provide new insights into the role of DISC1 in AD pathogenesis and link a potential function of DISC1 to the psychiatric symptoms of AD.
What problem does this paper attempt to address?